|
The mammomark biopsy site identifier is intended for use after an open surgical or percutaneous breast biopsy procedure to the biopsy site.The device is not available for analysis, which precludes a full investigation and analysis of the root cause.Our mammotome vacuum assisted biopsy probes contain extremely sharp edges along the aperture opening to effectively excise tissue.Removing the marker delivery system separately from the probe aperture once the spring is exposed creates the possibility of it catching on one of these edges.As a mitigation step to address this risk, we provide instructions within the instructions for use: directions: remove the delivery system and mammotome probe together as a single unit from the site, properly dispose and obtain images to confirm marker placement.Based on the patient consequence of an unintended piece of the device in the biopsy site, and the additional surgical procedure to remove, and pursuant to 21 cfr 803, we are submitting this medwatch report.
|
|
Devicor medical products inc.Received a report from the affiliate stating, "during the procedure, confirmed that the tip of the inserter was left in breast from the mammo mark 11 ref# mam3001 11g marker".The tip has not yet been removed from the patient.This patient will be scheduled for a more extensive surgery in the future.As of october 26, the patient had not experienced any complications.This has been documented as report # (b)(4).
|